Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CALL
Southern Company
SO
$107B
| $25M | 0.01% |
481,500
-254,400
| -35% | -$14.1M |
|
|
DRNA
1227
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $24.9M | 0.01% |
981,152
-1,045,646
| -52% | -$22.5M |
|
1228
Ziff Davis
ZD
$1.92B
| $24.8M | 0.01% |
451,976
+413,820
| +1,085% | +$27M |
|
|
K
1229
CALL
DELISTED
Kellanova
K
| $24.8M | 0.01% |
400,440
+60,385
| +18% | +$3.65M |
|
|
CIT
1230
DELISTED
CIT Group Inc.
CIT
| $24.8M | 0.01% |
1,197,629
-171,875
| -13% | -$3.32M |
|
1231
PUT
Vale
VALE
$58.7B
| $24.7M | 0.01% |
2,398,500
-658,300
| -22% | -$6.02M |
|
1232
DraftKings
DKNG
$12.6B
| $24.7M | 0.01% |
743,131
+709,630
| +2,118% | +$19.6M |
|
1233
Cadence Design Systems
CDNS
$89.2B
| $24.7M | 0.01% |
257,219
-3,707,580
| -94% | -$310M |
|
1234
PUT
Apollo Global Management
APO
$84.8B
| $24.7M | 0.01% |
494,000
-2,600
| -0.5% | -$114K |
|
1235
PUT
KLA
KLAC
$274B
| $24.7M | 0.01% |
1,268,000
+189,000
| +18% | +$3.23M |
|
1236
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $24.6M | 0.01% |
225,346
+179,237
| +389% | +$18.5M |
|
1237
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
| $24.6M | 0.01% |
199,400
+74,100
| +59% | +$7.36M |
|
1238
Ameren
AEE
$30.1B
| $24.6M | 0.01% |
348,972
-65,681
| -16% | -$4.76M |
|
1239
CALL
Eaton
ETN
$176B
| $24.5M | 0.01% |
280,200
+22,600
| +9% | +$1.86M |
|
|
KSU
1240
CALL
DELISTED
Kansas City Southern
KSU
| $24.5M | 0.01% |
163,800
+50,700
| +45% | +$7.13M |
|
|
SNV
1241
DELISTED
Synovus
SNV
| $24.4M | 0.01% |
1,190,637
-2,315,292
| -66% | -$44.8M |
|
1242
PUT
Cencora
COR
$59.2B
| $24.4M | 0.01% |
242,500
+104,000
| +75% | +$9.58M |
|
1243
PUT
Prologis
PLD
$134B
| $24.4M | 0.01% |
261,400
+70,600
| +37% | +$6.3M |
|
1244
Kinross Gold
KGC
$31.9B
| $24.4M | 0.01% |
3,377,274
-4,322,216
| -56% | -$28M |
|
1245
CALL
Equinix
EQIX
$106B
| $24.4M | 0.01% |
34,700
-7,000
| -17% | -$4.74M |
|
|
BNY
1246
PUT
Bank of New York Mellon
BNY
$110B
| $24.3M | 0.01% |
628,200
+350,900
| +127% | +$12.8M |
|
1247
Alphabet (Google) Class C
GOOG
$4.21T
| $24.2M | 0.01% |
343,060
-887,100
| -72% | -$59.9M |
|
|
AAN.A
1248
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $24.2M | 0.01% |
533,789
-441,480
| -45% | -$20M |
|
1249
CALL
Ciena
CIEN
$62.7B
| $24.2M | 0.01% |
447,200
+35,000
| +8% | +$1.74M |
|
1250
PUT
Lennar Class A
LEN
$21.1B
| $24.2M | 0.01% |
405,453
+206,910
| +104% | +$10.6M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.